KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Repurchased
Ratios

Pacira BioSciences (PCRX) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Pacira BioSciences (PCRX) over the last 17 years, with Q3 2025 value amounting to $221.5 million.

  • Pacira BioSciences' Other Gross PP&E Adjustments fell 304.75% to $221.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $221.5 million, marking a year-over-year decrease of 304.75%. This contributed to the annual value of $250.9 million for FY2024, which is 107.29% up from last year.
  • As of Q3 2025, Pacira BioSciences' Other Gross PP&E Adjustments stood at $221.5 million, which was down 304.75% from $232.8 million recorded in Q2 2025.
  • Pacira BioSciences' 5-year Other Gross PP&E Adjustments high stood at $250.9 million for Q4 2024, and its period low was $147.3 million during Q1 2021.
  • Its 5-year average for Other Gross PP&E Adjustments is $205.4 million, with a median of $211.2 million in 2022.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first skyrocketed by 5724.71% in 2021, then crashed by 304.75% in 2025.
  • Pacira BioSciences' Other Gross PP&E Adjustments (Quarter) stood at $197.2 million in 2021, then grew by 16.67% to $230.1 million in 2022, then grew by 7.86% to $248.2 million in 2023, then grew by 1.07% to $250.9 million in 2024, then dropped by 11.71% to $221.5 million in 2025.
  • Its last three reported values are $221.5 million in Q3 2025, $232.8 million for Q2 2025, and $212.5 million during Q1 2025.